BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170715
DTEND;VALUE=DATE:20170729
DTSTAMP:20170715T220030Z
CREATED:20170715T215145Z
LAST-MODIFIED:20170715T220030Z
UID:18730-1500076800-1501286399@ces.b2sg.org
SUMMARY:The Brain Tumour Charity - Future Leaders
DESCRIPTION:Funding\nThe scheme runs in three parts (Postdoctoral fellowship\, Junior Fellowship and Senior Fellowship)\, with only those entering the scheme as postdoctoral researchers eligible for the latter grants. Evidence must be provided that the named researcher is of the highest calibre and has the potential to be a future leader of the field. It is envisaged that the Senior Fellowship will be based in the UK and\, as such\, only applicants open to move to the UK should apply. \nThe initial stage of this scheme is to support a named Postdoctoral Fellow over a period of three years. The funding limit is £180\,000over this period and the application must address one of the areas identified in ‘A Cure Can’t Wait‘. \nAt the end of the first stage\, successful applicants will be invited to submit a further application for a Junior Fellowship\, available for four years of funding. The amount awarded for this period will total up to £480\,000 to support themselves and a research associate in a host laboratory. The programme of work should continue to develop the themes that they have been working on as a Postdoctoral Fellow. However\, it is expected that the researcher will begin to develop their own group and independent research. \nFinally\, upon successful application\, a Senior Fellowship will be awarded with up to £1\,000\,000 for five years to support the applicant and a small group. Again\, the research should be carried out in a host laboratory that will enable the further development of the applicant to become a fully independent group leader. This senior post must be at a UK university or institute. \nAll rounds will be competitively assessed with interview panels being convened for all fellowships\, either in person or via video conferencing. Applicants will be encouraged to find different host institutions\, and thus different mentors\, throughout the process to ensure a diverse exposure to techniques and concepts. \nSuccessful applicants will be expected to engage with The Charity to build a network of researchers and promote this scheme and the aims of The Charity. \nApplication process\nApplications will open on 8 June 2017 and will undergo a two stage approach: \nLetter of intent will be requested until 5 p.m. (London time) on 28 July 2017. This MUST be submitted by the Mentor. \nSuccessful applicants will then be requested to submit a full proposal until 5 p.m. on 20 October 2017. This MUST be submitted by the aspiring Fellow. \nApplications must be submitted online through our new portal: Proposal Central. Please do take the time to get familiar with the site\, set up an account and start filling in your profile. \nIn order to find our calls for applications visit this quick access link: letter of intent application form \nThe Brain Tumour Charity is a member of the Association of Medical Research Charities (AMRC) and adheres to its principles of peer review. Applications will be awarded through a competitive peer reviewed process (in line with AMRC principles) and then considered by our Scientific Advisory Boards (SABs). \n\n\n\n\nEligibility criteria\n\nAll grant applications must focus on the research priorities highlighted in our Research Strategy ‘A Cure Can’t Wait‘.\nThis scheme is initially open to international researchers. However\, Senior Fellowships must be taken up at a UK university or institute.\nThe named postdoctoral researcher must\, at the date of the call deadline\, be in possession of a doctoral degree. Clinicians moving into full time laboratory based research are welcome to apply\, providing they also fulfil the above criteria.\nThe named postdoctoral researcher’s previous research need not necessarily be in the brain tumour field\, but they must be able to demonstrate how they will apply their prior learning to the study of brain tumours.\nOnly applicants who have been awarded a Postdoctoral Fellowship on the scheme are eligible to apply for a Junior Fellowship. Following that\, only applicants who have been awarded a Junior Fellowship are eligible to apply for a Senior Fellowship.\nApplicants should seek different mentors\, at different host institutions\, throughout the process to ensure a diverse exposure to techniques and concepts.\nThe Mentor must hold an employment contract beyond the period of the grant.\nThe Host Institution should provide additional transferable skills training to the Fellow\, such as planning and writing of publications\, project management\, supervision of junior lab members and presentations in conferences and to the general public.\nAs they go through the scheme\, fellows are expected to show greater maturity and independence from their mentors.\nAll applications shall have input from those affected by brain tumours as early as possible\, preferably during scoping of the project. You may choose to access our Research Involvement Network (RIN) for Public Patient Involvement.\n\nAssessment criteria\nPotential of the Fellow\nThe Fellow must be appropriately trained and be able to demonstrate a strong track record in scientific research. They should be well suited to carry out the planned studies and applications must contribute to the development of the Fellow\, allowing them to reach a position of professional maturity/independence. At all applications stages\, Fellows must evidence now their willingness to relocate to the UK to take up a Senior Fellowship. \nExpertise of Mentors\nMentors must be well positioned to provide the Fellow with appropriate training\, supervision and mentoring to help them establish themselves as independent researchers. There should be identifiable programmes for personal development at the Host Institution that the Fellow can be enrolled upon. \nMethodology\nProjects must have a sound approach and methodology in order to address the questions raised while exposing the Fellow to different techniques. \nPotential for patient benefit\nA potential pathway for the research project to lead to patient benefit must be articulated as well as the anticipated impact of this. Applications with a clear path to clinical application will be strongly favoured. \nValue for money\nProjects must demonstrate that the funds requested are essential for the work and how these represent value for money. Leveraging matching funding from other organisations will be favoured. \n\n\nKey dates\n5pm on 28 July 2017 – Deadline for receipt of letter of intent \nEnd August 2017 – Invitation for submission of full applications \n5pm on 20 October 2017 – Deadline for receipt of full applications \nMarch 2018 – Biomedical SAB meeting \nMarch 2018– Awards announced \n\n\n\n\nFurther information\nPlease note: applicants should not\, under any circumstances\, directly approach Trustees or committee members in connection with their (or another’s) research application. \nAll applications shall have input from those affected by brain tumours as early as possible. To facilitate this you may choose to engage The Charity’s Research Involvement Network (RIN)\, a virtual network of people who either have a brain tumour themselves or care for someone who does. Information on contacting the RIN can be found at thebraintumourcharity.org/our-research/for-researchers/patient-public-involvement
URL:https://ces.b2sg.org/event/braintumourcharity-7-17/
LOCATION:The Brain Tumor Charity\, 65 Victoria Rd\, Farnborough\, GU14\, United Kingdom
CATEGORIES:Grants
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/07/thebraintumourcharity_-2-e1500138003862.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160831
DTEND;VALUE=DATE:20160901
DTSTAMP:20160419T161802Z
CREATED:20160419T020949Z
LAST-MODIFIED:20160419T161802Z
UID:14924-1472601600-1472687999@ces.b2sg.org
SUMMARY:Translationale Onkologie (Translational Oncology)
DESCRIPTION:With the goal of further supporting collaborative translational cancer research projects at ‘Interdisciplinary Oncology Centers of Excellence’ and Comprehensive Cancer Centers\, the German Cancer Aid has decided to launch a third call for applications within the funding program ‘Translational Oncology’. Projects may be collaborative scientific projects (‘Verbundprojekte’) or innovative clinical trials\, which must be performed at more than two sites and necessitate close collaboration between several research groups. \nDuration of funding: – \nCoverd costs:  €7.000.000 annually \nNationality: At least one research group must be located at an ‘Interdisciplinary Oncology Center of Excellence’ funded by the German Cancer Aid.
URL:https://ces.b2sg.org/event/translationale-onkologie/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/deutsche-Krebshilfe.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160629
DTEND;VALUE=DATE:20160630
DTSTAMP:20160419T152345Z
CREATED:20160419T020320Z
LAST-MODIFIED:20160419T152345Z
UID:14923-1467158400-1467244799@ces.b2sg.org
SUMMARY:Quality of Life Research Grant
DESCRIPTION:Quality of Life Research Grants have been created to support quality of life cancer research that has the potential to make a significant impact on the burden of disease in patients\, survivors and caregivers. These grants are intended to explore psychosocial\, survivorship\, symptom control\, supportive care and end-of-life issues\, research gaps\, needs and opportunities\, or models for survivorship care. The grants are meant to accelerate and focus the knowledge gained from scientific findings\, in the short or long term\, into outcomes that will result in the reduced burden or enhanced quality of life for cancer patients in Canada and elsewhere. \nDuration of funding: – \nCoverd costs: \nNationality: Canada
URL:https://ces.b2sg.org/event/quality-of-life-research-grant/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/canadian-cancer-society.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160617
DTEND;VALUE=DATE:20160618
DTSTAMP:20160419T151714Z
CREATED:20160419T020042Z
LAST-MODIFIED:20160419T151714Z
UID:14921-1466121600-1466207999@ces.b2sg.org
SUMMARY:Postdoctoral Fellowship grants
DESCRIPTION:PDF Grants seek to attract and support promising scientists embarking on careers dedicated to breast cancer research and who have no more than 3 years post-completion of their most recent clinical fellowship\, 5 years post-completion of their most recent residency (for physicians)\, or 5 years post-completion of their most recent Ph.D. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor\, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. PDF Grants provide support for research projects that have significant potential to advance our understanding of breast cancer\, lead to reductions in breast cancer incidence and/or mortality\, and move us toward the goal of a world without breast cancer. \nDuration of funding: 2-3 years \nCoverd costs:  Up to $180\,000 direct costs only ($60\,000 per year) \nNationality: not required to be a U.S. citizen or resident
URL:https://ces.b2sg.org/event/postdoctoral-fellowship-grants/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/susan-g-komen.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160617
DTEND;VALUE=DATE:20160618
DTSTAMP:20160419T151702Z
CREATED:20160419T015720Z
LAST-MODIFIED:20160419T151702Z
UID:14917-1466121600-1466207999@ces.b2sg.org
SUMMARY:Career Catalyst Research Grants (CCR)
DESCRIPTION:CCR Grants provided by Susan G. Komen Organistaion support unique opportunities for scientists who have held faculty positions for no more than six years at the time of full application to achieve research independence. CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer\, lead to reductions in breast cancer incidence and/or mortality\, and move us toward the goal of a world without breast cancer.There are two research focus areas: Basic/Translational and Clinical. \nDuration of funding: up to 3 years \nCoverd costs:  $450\,000 combined direct and indirect costs; ($150\,000 per year for up to 3 years) \nNationality: not required to be a U.S. citizen or resident
URL:https://ces.b2sg.org/event/career-catalyst-research-grants-ccr/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/susan-g-komen.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160606
DTEND;VALUE=DATE:20160607
DTSTAMP:20160502T122900Z
CREATED:20160419T015139Z
LAST-MODIFIED:20160502T122900Z
UID:14915-1465171200-1465257599@ces.b2sg.org
SUMMARY:Future Research Leader Fellowships (FRL)
DESCRIPTION:5 year full time Fellowships to provide salary and project support to encourage high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution. \nDuration of funding: 5 years \nCoverd costs:  salary and project support \nNationality: Australia
URL:https://ces.b2sg.org/event/future-research-leader-fellowships-frl/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/nsw.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160530
DTEND;VALUE=DATE:20160531
DTSTAMP:20160502T123146Z
CREATED:20160419T014858Z
LAST-MODIFIED:20160502T123146Z
UID:14914-1464566400-1464652799@ces.b2sg.org
SUMMARY:Career Development Fellowships (CDF)
DESCRIPTION:3 year full time fellowships to provide salary and project support to encourage the very best researchers (up to 10 years post doc) to continue independent cancer research that is nationally and internationally competitive. \nDuration of funding: 3 years \nCoverd costs:  $200\,000 annually \nNationality: Australia
URL:https://ces.b2sg.org/event/career-development-fellowships-cdf/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/nsw.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160530
DTEND;VALUE=DATE:20160531
DTSTAMP:20160428T175208Z
CREATED:20160419T014556Z
LAST-MODIFIED:20160428T175208Z
UID:14911-1464566400-1464652799@ces.b2sg.org
SUMMARY:Early Career Fellowships (ECF)
DESCRIPTION:3 year full time fellowships to provide salary and project support to encourage the very best researchers (up to 5 years post doc) to choose cancer research as their career and to continue independent research that is nationally and internationally competitive (max $200\,000 p.a x 3 years). \nDuration of funding: 3 years \nCoverd costs:   $200\,000 annually \nNationality: The Administering Institution must be registered with the Cancer Institute NSW
URL:https://ces.b2sg.org/event/early-career-fellowships-ecf/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/nsw.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160506
DTEND;VALUE=DATE:20160507
DTSTAMP:20160419T151535Z
CREATED:20160419T013938Z
LAST-MODIFIED:20160419T151535Z
UID:14909-1462492800-1462579199@ces.b2sg.org
SUMMARY:Ann Schreiber Mentored Investigator Award
DESCRIPTION:The Ann Schreiber Mentored Investigator Award (formerly the Ann Schreiber Research Training Programs of Excellence Award) provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research. Applicants must be clinical fellows (Gynecologic Oncology\, Medical Oncology)\, or post-doctoral fellows. Candidates for this program must have an MD or a PhD degree. This grant is named in honor of Ann Schreiber\, in whose memory OCRF was founded. \nDuration of funding: 1-2 years \nCoverd costs:  £75\,000 annually \nNationality: US
URL:https://ces.b2sg.org/event/ann-schreiber-mentored-investigator-award/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/ocrf.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160506
DTEND;VALUE=DATE:20160507
DTSTAMP:20160419T151148Z
CREATED:20160419T013809Z
LAST-MODIFIED:20160419T151148Z
UID:14907-1462492800-1462579199@ces.b2sg.org
SUMMARY:Liz Tilberis Early Career Award
DESCRIPTION:Launched in December 2000\, the Liz Tilberis Early Career Award (formerly called the Liz Tilberis Scholars Award) is for junior faculty with a strong commitment to an investigative career in ovarian cancer research. These awards support a substantial time commitment to research and academic endeavors in ovarian cancer. \nDuration of funding: 3 years \nCoverd costs:  £150\,000 annually \nNationality: US
URL:https://ces.b2sg.org/event/liz-tilberis-early-career-award/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/ocrf.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160506
DTEND;VALUE=DATE:20160507
DTSTAMP:20160419T150806Z
CREATED:20160419T013545Z
LAST-MODIFIED:20160419T150806Z
UID:14905-1462492800-1462579199@ces.b2sg.org
SUMMARY:Collaborative Research Development Grant
DESCRIPTION:Launched in 2004\, this research program provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. The grant is for investigators seeking to develop program project grant applications for submission to peer-review funding agencies (e.g. NCI\, RO1\, SPORE\, DOD). \nDuration: 3 years \nCovered costs:$300\,000 annually \nNationality: US
URL:https://ces.b2sg.org/event/collaborative-research-development-grant-formerly-named-program-project-development-grant/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/ocrf.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160429
DTEND;VALUE=DATE:20160430
DTSTAMP:20160419T155753Z
CREATED:20160419T011244Z
LAST-MODIFIED:20160419T155753Z
UID:14882-1461888000-1461974399@ces.b2sg.org
SUMMARY:The search for the best cancer research in the world
DESCRIPTION:Since 1979 “worldwide cancer research” has invested into nearly two thousand reseach projects all over the world. The goal of this grant is to support research that might in future help reduce the incidence of cancer or improve cancer survial. \nGrants are awarded to support fudamental or translational research into the causes\, mechanisms\, diagnosis\, treatment or prevention of cancer. \nDuration of funding: 1-3years \nCovered costs: direct costs of conducting the research \nNationality: international
URL:https://ces.b2sg.org/event/the-search-for-the-best-cancer-research-in-the-world/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/worldwide-cancer-research1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160217
DTEND;VALUE=DATE:20160218
DTSTAMP:20160111T213040Z
CREATED:20151218T171741Z
LAST-MODIFIED:20160111T213040Z
UID:11927-1455667200-1455753599@ces.b2sg.org
SUMMARY:Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)
DESCRIPTION:Purpose: to advance research in cancer etiology and early detection biomarkers\, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate\, Lung\, Colorectal\, and Ovarian Cancer (PLCO) Screening Trial
URL:https://ces.b2sg.org/event/utilizing-the-plco-biospecimens-resource-to-bridge-gaps-in-cancer-etiology-and-early-detection-research-u01-4/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/NIH2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160107
DTEND;VALUE=DATE:20160108
DTSTAMP:20151218T175506Z
CREATED:20151218T174519Z
LAST-MODIFIED:20151218T175506Z
UID:11932-1452124800-1452211199@ces.b2sg.org
SUMMARY:Research Grant Programm
DESCRIPTION:Supports research projects aimed at understanding the causes of breast cancer\, prevention or developing new treatments for metastatic breast cancer
URL:https://ces.b2sg.org/event/research-grant-programm/
CATEGORIES:Grants
END:VEVENT
END:VCALENDAR